MetaCap

Telomir Pharmaceuticals (TELO) News

NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.364-0.0758 (-17.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TELO news summary

We found 2 recent headlines mentioning Telomir Pharmaceuticals (TELO): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. TELO is making an outsized move today, down 17.24% at $0.364, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Telomir Pharmaceuticals, Inc. Selects Linical to Support Phase 1/2 Clinical Trial of Telomir-Zn", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Telomir Pharmaceuticals headlines

Compare TELO